CPT code 87652 represents a molecular diagnostic test that detects and quantifies infection with Streptococcus, group A, using a nucleic acid probe technique. This CPT laboratory code is nationally relevant because group A Streptococcus causes common and sometimes serious infections; timely, accurate molecular testing informs clinical management and infection-control decisions.

Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the test, typical sites of service, and the service type (molecular laboratory testing). The publication summarizes common billing modifiers and coding context where available and highlights billing and coverage considerations that affect reimbursement workflows.

The report also outlines expected benchmarks for test utilization and coding practice, explains how the code fits within laboratory service lines, and summarizes any notable policy updates or payer guidance when available. Data not available in the input is clearly indicated where applicable. This national-level brief is intended to inform coders, billing managers, and laboratory directors about the clinical and administrative role of CPT code 87652.